Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 1304 composition records across product categories including Specialty occupational products, Raw materials, Home maintenance.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of MAGNESIUM ALUMINUM SILICATE in our catalog (epa_cpdat).
Products
1,304
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1304 composition records across product categories including Specialty occupational products, Raw materials, Home maintenance. EPA CPDat classifies this chemical for functional uses including Absorbent, Opacifer, Viscosity modifier.
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 0.4 %w/w
US
FDA
Nivea Men Dry Impact
Nivea
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 60 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 410 mg/5ml
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: 12.5 mg/5ml
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Potency: 5000 mg/5ml
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Potency: 4.15 mg/2.5ml
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 70 mg
US
FDA
Route: RECTAL; Dosage form: SUSPENSION; Maximum daily exposure: 14480 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 1.5 %w/w
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1.25 %w/w
US
FDA
Route: VAGINAL; Dosage form: OINTMENT; Maximum daily exposure: 231 mg
US
FDA
openFDA substance registry classifies this ingredient as mixture.